Omar H. Butt

2.2k total citations · 1 hit paper
51 papers, 1.1k citations indexed

About

Omar H. Butt is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Omar H. Butt has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Omar H. Butt's work include Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (8 papers) and Visual perception and processing mechanisms (7 papers). Omar H. Butt is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (8 papers) and Visual perception and processing mechanisms (7 papers). Omar H. Butt collaborates with scholars based in United States, Canada and Ireland. Omar H. Butt's co-authors include Geoffrey K. Aguirre, Noah C. Benson, David H. Brainard, Ritobrato Datta, Beau M. Ances, Petya D. Radoeva, John C. Morris, David M. Holtzman, Suzanne E. Schindler and Anne M. Fagan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Omar H. Butt

44 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease

2023 180 citations Tammie L.S. Benzinger, David M. Holtzman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Omar H. Butt United States	17	449	290	179	134	97	51	1.1k
Aurélie Kas France	19	297 0.7×	130 0.4×	129 0.7×	184 1.4×	107 1.1×	73	1.2k
Jung‐Ick Byun South Korea	26	429 1.0×	430 1.5×	210 1.2×	65 0.5×	241 2.5×	123	2.5k
Martina Wengenroth Germany	15	386 0.9×	147 0.5×	69 0.4×	117 0.9×	49 0.5×	19	875
Tianyi Qian China	20	600 1.3×	114 0.4×	71 0.4×	627 4.7×	84 0.9×	58	1.5k
Pedro M. Faustmann Germany	21	197 0.4×	374 1.3×	137 0.8×	23 0.2×	247 2.5×	58	1.4k
Joshua Wang United States	13	409 0.9×	93 0.3×	143 0.8×	28 0.2×	167 1.7×	34	890
Anil Ramlackhansingh United Kingdom	12	237 0.5×	367 1.3×	124 0.7×	218 1.6×	232 2.4×	25	1.7k
Frank Angenstein Germany	26	426 0.9×	543 1.9×	123 0.7×	165 1.2×	616 6.4×	65	1.7k
Huiqing Dong China	22	716 1.6×	140 0.5×	118 0.7×	654 4.9×	68 0.7×	61	1.5k
Yumiko Nishikawa Japan	21	265 0.6×	151 0.5×	45 0.3×	185 1.4×	47 0.5×	40	1.1k

Countries citing papers authored by Omar H. Butt

Since Specialization

Citations

This map shows the geographic impact of Omar H. Butt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar H. Butt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar H. Butt more than expected).

Fields of papers citing papers by Omar H. Butt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar H. Butt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar H. Butt. The network helps show where Omar H. Butt may publish in the future.

Co-authorship network of co-authors of Omar H. Butt

This figure shows the co-authorship network connecting the top 25 collaborators of Omar H. Butt. A scholar is included among the top collaborators of Omar H. Butt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar H. Butt. Omar H. Butt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Yitong, Tatiana Simon, Omar H. Butt, et al.. (2025). Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma. Journal of Neuro-Oncology. 176(1). 36–36.

Campian, Jian, Omar H. Butt, Marc D. Ruben, et al.. (2025). Tracking Daily Variations in Rest-Wake to Guide Personalized Timing of Temozolomide for High-Grade Glioma Patients. Journal of Biological Rhythms. 40(4). 320–329. 1 indexed citations

Adeyelu, Tolulope, Andrew Elliott, Farah Abdulla, et al.. (2024). Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma. npj Precision Oncology. 8(1). 187–187. 7 indexed citations

Huang, Jiayi, Jian Campian, T.A. DeWees, et al.. (2024). A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 120(3). 738–749. 11 indexed citations

Liu, Wei, Yiran Huang, Omar H. Butt, et al.. (2024). A Pilot Study of Temporally-Modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-Mutant Gliomas after Prior External Beam Radiation Therapy: An Interim Analysis. International Journal of Radiation Oncology*Biology*Physics. 120(2). e252–e253.

Luo, Jingqin, Christopher L. Grote, Leslie Nehring, et al.. (2024). CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA. Neuro-Oncology. 26(Supplement_8). viii90–viii91.

Ghosh, Subhajit, Tanner M. Johanns, Milan G. Chheda, et al.. (2023). A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma. Neuro-Oncology Advances. 5(1). vdad088–vdad088. 5 indexed citations

Zhou, Alice Y., et al.. (2023). Determining PARP Inhibition as a Treatment Strategy in Melanoma Based on Homologous Recombination Deficiency–Related Loss of Heterozygosity. Journal of the National Comprehensive Cancer Network. 21(7). 688–693.e3. 8 indexed citations

Khaddour, Karam, et al.. (2023). Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma. Frontiers in Oncology. 13. 1276729–1276729. 4 indexed citations

10.

Wisch, Julie K., Omar H. Butt, Brian A. Gordon, et al.. (2022). Proteomic clusters underlie heterogeneity in preclinical Alzheimer’s disease progression. Brain. 146(7). 2944–2956. 5 indexed citations

11.

Luo, Jingqin, Emily A. Slat, Katherine N. Weilbaecher, et al.. (2022). A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma. Neuro-Oncology Practice. 9(3). 193–200. 21 indexed citations

12.

Hwang, Helen, Jiayi Huang, Karam Khaddour, et al.. (2022). Prolonged response of recurrent IDH -wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab. CNS Oncology. 11(1). 23 indexed citations

13.

Khaddour, Karam, et al.. (2022). Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios. Frontiers in Oncology. 12. 978996–978996. 6 indexed citations

14.

Butt, Omar H., Brian A. Gordon, Anne M. Fagan, et al.. (2022). Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage. Neurobiology of Disease. 166. 105662–105662. 37 indexed citations

15.

Lucey, Brendan P., Julie K. Wisch, Anna H. Boerwinkle, et al.. (2021). Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer’s disease. Brain. 144(9). 2852–2862. 87 indexed citations

16.

Butt, Omar H., Justin M. Long, Rachel L. Henson, et al.. (2021). Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25. Neurobiology of Aging. 102. 64–72. 10 indexed citations

17.

Butt, Omar H., Alice Y. Zhou, Jiayi Huang, et al.. (2021). A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Neuro-Oncology Advances. 3(1). vdab164–vdab164. 38 indexed citations

18.

Aguirre, Geoffrey K., Omar H. Butt, Ritobrato Datta, et al.. (2017). Postretinal Structure and Function in Severe Congenital Photoreceptor Blindness Caused by Mutations in the GUCY2D Gene. Investigative Ophthalmology & Visual Science. 58(2). 959–959. 12 indexed citations

19.

Benson, Noah C., Omar H. Butt, Rahul Datta, David H. Brainard, & Geoffrey K. Aguirre. (2011). A Universal Retinotopic Mapping of V1 with Respect to Anatomy. Journal of Vision. 11(11). 1067–1067. 2 indexed citations

20.

Arya, Arvind, Omar H. Butt, & A. Nigam. (2003). Double-blind randomised controlled trial comparing Merocel with Rapid Rhino nasal packs after routine nasal surgery.. PubMed. 41(4). 241–3. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact